| BACHEM HLDG NA SF 0,01 |
| Schweiz |
| Gesundheit |
| CH1176493729 / A3DLKE |
| BHM0 (Frankfurt) |
| FRA:BHM0, ETR:BHM0, BHM0:GR |
| - |
| https://www.bachem.com/ |
|
Bachem Holding AG is a Swiss biotechnology company specializing in the development and manufacturing of peptides and oligonucleotides for research, clinical development, and commercial applications. F..
>Volltext.. |
| 4583.22 Mio. EUR |
| 4611.7 Mio. EUR |
| 760.9 Mio. EUR |
| 207.86 Mio. EUR |
| 162.88 Mio. EUR |
| 2.17 EUR |
| 62.83 Mio. EUR |
| 33.92 Mio. EUR |
| 297.06 Mio. EUR |
| 0.08 |
| 15.96% |
| 24.94% |
| - |
| 1.55% |
| 1.55% |
| 21.04.23 - 0.810825€ 29.04.22 - 0.151353992€ >weitere anzeigen... |
| - |
| BACHEM |
| 14.03.26 |
|
||||
|
||||
|